Profil
Craig J.
Tuttle served as President, Chief Executive Officer & Director at Transgenomic, Inc. from 2012 to 2013.
Prior to that, he was President & Chief Executive Officer at Applied Biotech, Inc. from 1999 to 2003 and President & Chief Operating Officer at Duke Scientific Corp.
from 2004 to 2005.
Tuttle received his undergraduate degree from the University of California, Los Angeles, his MBA from St. Mary's College (Indiana), and his graduate degree from The University of Colorado.
Anciens postes connus de Craig J. Tuttle
| Sociétés | Poste | Fin |
|---|---|---|
Transgenomic, Inc.
 Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Directeur Général | 30/09/2013 |
Duke Scientific Corp.
 Duke Scientific Corp. Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Duke Scientific Corp. develops medical instruments. The company is based in Palo Alto, CA. Duke Scientific was acquired by Fisher Scientific International, Inc. on October 03, 2005. | President | 01/01/2005 |
| Applied Biotech, Inc. | President | 01/01/2003 |
Formation de Craig J. Tuttle
| University of California, Los Angeles | Undergraduate Degree |
| The University of Colorado | Graduate Degree |
| St. Mary's College (Indiana) | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
Duke Scientific Corp.
Duke Scientific Corp. Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Duke Scientific Corp. develops medical instruments. The company is based in Palo Alto, CA. Duke Scientific was acquired by Fisher Scientific International, Inc. on October 03, 2005. | Health Technology |
| Applied Biotech, Inc. | Health Technology |
